Venkat Sethuraman, PhD, MBA serves as the senior vice president of Global Biometrics and Data Sciences at Bristol Myers Squibb, where he is accountable for the biostatistics/quantitative support to Global Development and Medical organization. In addition, Venkat leads the Innovation Pillar for the Global Drug Development, developing the data and digital strategy by utilizing data science, advanced clinical trial solutions and robust digital tools to accelerate the pipeline. Venkat and his team are working at the forefront of how Bristol Myers Squibb is utilizing digital innovation to revolutionize drug development by harnessing the power of big data, artificial intelligence (AI) and machine learning approaches to power prediction from the earliest inception of our programs.
Prior to ZS, Venkat held various leadership roles at BMS, Novartis Oncology and GSK. Venkat has diverse research interests and consulting experience in industry that includes clinical trials design, innovative trial models, data science, and most recently, digital efforts in clinical research.
Venkat received a PhD in statistics from Temple University and an MBA from the Wharton School of the University of Pennsylvania. He currently serves on the Board of Association for Women in Science (AWIS) and has served on the board of the Biopharmaceutical Section of the American Statistical Association.
